Actavis antibiotic combo Avycaz OK'd for 2 infections
This article was originally published in Scrip
Executive Summary
Actavis won the FDA's approval on 25 February to market Avycaz, an antibiotic combination containing ceftazidime and avibactam, to treat complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI).